Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Oligochitosan polyplexes as carriers for retinal gene delivery.

Puras G, Zarate J, Díaz-Tahoces A, Avilés-Trigueros M, Fernández E, Pedraz JL.

Eur J Pharm Sci. 2013 Jan 23;48(1-2):323-31. doi: 10.1016/j.ejps.2012.11.009. Epub 2012 Nov 29.

PMID:
23201002
2.

Low molecular weight oligochitosans for non-viral retinal gene therapy.

Puras G, Zarate J, Aceves M, Murua A, Díaz AR, Avilés-Triguero M, Fernández E, Pedraz JL.

Eur J Pharm Biopharm. 2013 Feb;83(2):131-40. doi: 10.1016/j.ejpb.2012.09.010. Epub 2012 Oct 8.

PMID:
23059418
3.

Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.

Agirre M, Zarate J, Puras G, Ojeda E, Pedraz JL.

Drug Deliv. 2015 Jan;22(1):100-10. doi: 10.3109/10717544.2013.871373. Epub 2014 Jan 28.

PMID:
24471693
4.

Delivery of an adenovirus vector plasmid by ultrapure oligochitosan based polyplexes.

Agirre M, Zarate J, Ojeda E, Puras G, Rojas LA, Alemany R, Pedraz JL.

Int J Pharm. 2015 Feb 20;479(2):312-9. doi: 10.1016/j.ijpharm.2014.12.062. Epub 2014 Dec 27.

PMID:
25550211
5.

A novel cationic niosome formulation for gene delivery to the retina.

Puras G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Martínez Navarrete G, Avilés-Trigueros M, Fernández E, Pedraz JL.

J Control Release. 2014 Jan 28;174:27-36. doi: 10.1016/j.jconrel.2013.11.004. Epub 2013 Nov 11.

PMID:
24231407
6.

A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina.

Ochoa GP, Sesma JZ, Díez MA, Díaz-Tahoces A, Avilés-Trigeros M, Grijalvo S, Eritja R, Fernández E, Pedraz JL.

Pharm Res. 2014 Jul;31(7):1665-75. doi: 10.1007/s11095-013-1271-5. Epub 2014 Jan 22.

PMID:
24449439
7.

The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain.

Ojeda E, Puras G, Agirre M, Zarate J, Grijalvo S, Eritja R, Martinez-Navarrete G, Soto-Sánchez C, Diaz-Tahoces A, Aviles-Trigueros M, Fernández E, Pedraz JL.

Biomaterials. 2016 Jan;77:267-79. doi: 10.1016/j.biomaterials.2015.11.017. Epub 2015 Nov 14.

PMID:
26610076
8.

Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine.

Puras G, Martínez-Navarrete G, Mashal M, Zárate J, Agirre M, Ojeda E, Grijalvo S, Eritja R, Diaz-Tahoces A, Avilés-Trigueros M, Fernández E, Pedraz JL.

Mol Pharm. 2015 Oct 5;12(10):3658-71. doi: 10.1021/acs.molpharmaceut.5b00422. Epub 2015 Sep 11.

PMID:
26334586
9.

New gene delivery system based on oligochitosan and solid lipid nanoparticles: 'in vitro' and 'in vivo' evaluation.

Delgado D, del Pozo-Rodríguez A, Angeles Solinís M, Bartkowiak A, Rodríguez-Gascón A.

Eur J Pharm Sci. 2013 Nov 20;50(3-4):484-91. doi: 10.1016/j.ejps.2013.08.013. Epub 2013 Aug 25.

PMID:
23981333
10.

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Li W, Kong F, Li X, Dai X, Liu X, Zheng Q, Wu R, Zhou X, Lü F, Chang B, Li Q, Hauswirth WW, Qu J, Pang JJ.

Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.

11.

Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.

Martens TF, Remaut K, Deschout H, Engbersen JF, Hennink WE, van Steenbergen MJ, Demeester J, De Smedt SC, Braeckmans K.

J Control Release. 2015 Mar 28;202:83-92. doi: 10.1016/j.jconrel.2015.01.030. Epub 2015 Jan 26.

PMID:
25634806
12.

Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs.

Zhang S, Wu J, Wu X, Xu P, Tian Y, Yi M, Liu X, Dong X, Wolf F, Li C, Huang Q.

Invest Ophthalmol Vis Sci. 2012 May 4;53(6):2675-84. doi: 10.1167/iovs.11-8856.

PMID:
22427581
13.

Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo.

Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF.

Gene Ther. 2009 Sep;16(9):1146-53. doi: 10.1038/gt.2009.84. Epub 2009 Jul 2.

PMID:
19571889
14.

[Transduction efficacy of recombinant type 1 and type 2 adeno-associated virus in the retinal cells].

Wu JH, Zhang SH, Liu Y, Chen XF, Xu P, Wu XB, Huang Q.

Zhonghua Yi Xue Za Zhi. 2006 Oct 31;86(40):2841-6. Chinese.

PMID:
17200021
15.

Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells.

del Pozo-Rodríguez A, Delgado D, Solinís MA, Gascón AR, Pedraz JL.

Int J Pharm. 2008 Aug 6;360(1-2):177-83. doi: 10.1016/j.ijpharm.2008.04.023. Epub 2008 Apr 22.

PMID:
18508211
16.

Water-soluble and low molecular weight chitosan-based plasmid DNA delivery.

Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW.

Pharm Res. 2001 Apr;18(4):427-31.

PMID:
11451027
17.

Neonatal systemic delivery of scAAV9 in rodents and large animals results in gene transfer to RPE cells in the retina.

Joussemet B, Belbellaa B, Mendes-Madeira A, Bucher T, Briot-Nivard D, Dubreil L, Colle MA, Cherel Y, Moullier P, Rolling F.

Exp Eye Res. 2011 Oct;93(4):491-502. doi: 10.1016/j.exer.2011.06.012. Epub 2011 Jun 24.

PMID:
21723863
18.

[Liposome-mediated gene transfer into retina].

Wang F, Xia X, Hu H, Li L, Tian Y, Chen X, Huang Q.

Zhonghua Yan Ke Za Zhi. 2002 Sep;38(9):520-2. Chinese.

PMID:
12410968
19.

Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?

Glushakova LG, Timmers AM, Issa TM, Cortez NG, Pang J, Teusner JT, Hauswirth WW.

Mol Vis. 2006 Apr 7;12:298-309.

20.

Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo.

Hirano Y, Sakurai E, Matsubara A, Ogura Y.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):508-15. doi: 10.1167/iovs.09-3457. Epub 2009 Jul 2.

PMID:
19578010

Supplemental Content

Support Center